Lena Volland/flowlab-science
Apr 6, 2026, 05:34
Lena Volland: Scientific Exchange in Bleeding Disorders at the WFH 2026 World Congress
Lena Volland, Founder and CEO of FlowLab, shared a post on LinkedIn:
“Now that it’s April, I am getting very excited about the WFH Congress in Kuala Lumpur later this month.
This year, I have the honor of speaking on several topics that are extremely close to my heart.
But I’m also really looking forward to reconnecting with old friends from all over the world, meeting new people, and learning from each other along the way.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026
-
Jul 13, 2026, 16:06Dino Mehic: Honored to Receive the ISTH Early Career Top Reviewer Awards
-
Jul 13, 2026, 16:01Advancing DIC Diagnosis in Cirrhosis Through Disease-Specific Risk Stratification – JTH
-
Jul 13, 2026, 15:52Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
-
Jul 13, 2026, 15:42Marc Carrier: Important New Data From the API-CAT Trial on Recurrent VTE During Extended Apixaban Therapy
-
Jul 13, 2026, 15:23Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
-
Jul 13, 2026, 15:15Alfonso J. Tafur: Insights on Periprocedural DOAC Management in Atrial Fibrillation at ISTH 2026